Company / Return on Assets (ROA)
Corbus Pharmaceuticals Holdings, Inc. Return on Assets (ROA) History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-68.8%
FY2022
5-year range
-113.3% / -68.8%
FY2018-FY2022
Trend
+33.4%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 8 years, ranging from -113.3% in FY2019 to -13.2% in FY2017.
Based on SEC 10-K filings.
-68.8% in FY2022 with a 5-year CAGR of -55.6%.
Remained stable around -68.8% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +44.5pp
- 5-Year Change
- -55.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2022, return on assets (roa) increased 33.4% year-over-year.
- Peak return on assets (roa) was recorded in FY2017.
- Lowest return on assets (roa) in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2022 | -68.8% | +33.4% |
| FY2021 | -103.3% | -47.9% |
| FY2020 | -69.8% | +38.3% |
| FY2019 | -113.3% | -64.2% |
| FY2018 | -69.0% | -422.3% |
| FY2017 | -13.2% | +73.3% |
| FY2016 | -49.5% | -150.8% |
| FY2015 | -19.7% | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026